UAFRS vs As-Reported Weekly Highlights - 2018 10 31
This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for BA, VRTU, and ANIK.Anika Therapeutics is joint preservation and regenerative therapies company. The company's Joint Pain Management Therapies product family includes MONOVISC, ORTHOVISC, CINGAL, and HYVISC, hyaluronic acid (HA)-based intraarticular injectable products. The company's Orthopedic Joint Preservation and Restoration Care products include HYALOFAST, TACTOSET, Arthrosurface's catalogue of over 150 partial and total joint surface implants and preservation solutions for the knee, shoulder, hip, ankle, wrist and toe and Parcus Medical's line of surgical implant and instrumentation solutions. The company's Other product family consists of HA-based products that do not fit into one of its other primary product categories.
The Boeing is an aerospace firm. The company's segments include: Commercial Airplanes, which develops, produces and markets commercial jet aircraft and provides fleet support services, mainly to the commercial airline industry; Defense, Space and Security, which engages in the research, development, production and modification of manned and unmanned military aircraft and weapons systems for strike, surveillance and mobility, vertical lift, and commercial derivative aircraft; Global Services, which provides supply chain and logistics management, pilot and maintenance training systems and services, and data analytics and digital services; and Boeing Capital, which manages overall financing exposure.
Virtusa is a provider of digital engineering and information technology (IT) outsourcing services. The company's services include: Business and IT consulting services, which provide business and IT consulting services to assist its clients in managing their business and IT environments, and aligning their IT investments; Technology implementation services, which involve building, testing, deploying, maintaining and supporting IT applications, and consolidating and rationalizing its clients' existing IT applications and environments into platforms; and Application outsourcing services, which provide support for its clients' needs to manage and maintain their software applications and platforms.
In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:
- GAAP and IFRS have failed to provide rules for reliable financial statement reporting
- Stock analyst recommendations are not grounded in disciplined financial analysis
- Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
- Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available
We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.
- Corporate credit ratings remain years behind the fundamental underpinnings of company performance
- Stock analysts continue to make recommendations with deeply inherent biases
- Research firms have failed to break down the walls between credit, equity, and macroeconomic research
- The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming
The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.